Trending News

Setting a new standard with Performance-Guided Surgery   When the smart phone in your pocket has more computing power than the standard technology in our hospital operating rooms, it’s time for change. One small cap technology company is on a mission to disrupt the surgical landscape and set a new standard for the future of… [Read More]

Sci-Fi writers around the world are rejoicing as one of their shared visions becomes a reality. Mobileye, a global pioneer in autonomous vehicles (AVs) will start operating robotaxis in two international cities in 2022.  The AVs navigate with a camera-based system that utilizes lidar and radar. Is anyone else having a “Total Recall” flashback? This… [Read More]

Microsoft Overpays to Bring “Call of Duty” to Game Pass Gamers rejoice (or not). For a ridiculously overpriced $95 per share, Microsoft (MSFT) has agreed to buy Activision (ATVI), publishers of the classic “Call of Duty” game franchise. They’ll also get “World of Warcraft” and “Candy Crush.” All three should be on Game Pass later… [Read More]

Robinhood (HOOD) was overvalued when it went public last year at $38. Share prices hit their peak in August and they’ve been dropping like a stone since then. The Hood was at $14.90 pre-market this morning and it’s going down again today. Have you sold it yet? If not, you might want to do that… [Read More]

Elon Musk is a master manipulator. He knows that retail investors listen to him and often uses that to move the market. Last year, he announced a deal with Piedmont Lithium (PLL), touting it as a move to reduce US reliance on imports. Piedmont stock went up, despite them not being able to deliver. North… [Read More]

The Motley Fool called them a “dilution machine” last August, warning investors to “tread carefully.” Share prices are down 12.5% over the past twelve months. The company is on the cusp of being delisted by Nasdaq. On the surface, Sundial Growers (SNDL) looks like a disaster. Dig deeper. It’s my pick of the month in… [Read More]

Psychedelic drugs have come a long way since the ‘60s. Once hailed for social and recreational purposes, today LSD, magic mushrooms and other psychedelics are headlining clinical trials for novel treatments for depression and anxiety, addiction, PTSD and schizophrenia, among others. Big pharma is paying attention. Recently, the McQuade Center for Strategic Research and Development… [Read More]

Armed with supportive data from Phase II and III trials, share price showing strength and Company to pursue partnership opportunities for novel molecule Soligenix, Inc. (Nasdaq: SNGX) has demonstrated positive efficacy of dusquetide as an anti-tumor therapy in non-clinical animal studies. Previously published studies have also confirmed dusquetide’s efficacy in treating: Breast cancer: As a… [Read More]

We are witnessing an acceleration. Glimpses of it were granted to us in 2021. The memesters at Reddit pushed GameStop (GME) to an 800% return. Facebook (FB) branded itself as Meta and somehow became the metaverse. Trump Media, aka Digital World Acquisition Corp (DWAC), opened at $51 this morning. They were under $10 in October…. [Read More]

As of this morning, Bitcoin (BTC) is showing a 60% increase YTD. That’s a solid number most years, but not for the past twelve months we’ve just been through. Many fortunes were made and lost this year, and I’m not talking about meme stocks. Those are for traders. For my last editorial treatise of 2021,… [Read More]

  Science fiction is a genre of unlimited imagination, but it’s not fantasy. The great Sci-Fi writers of the twentieth century introduced us to strange new worlds and unbelievable technologies. Those weren’t made up out of thin air. Asimov, Heinlein, Bradbury, and Roddenberry did their research. Most of those ideas were based in real scientific… [Read More]

When you think of Tom Brady and Aaron Rogers, you probably think of Super Bowl rings, winning percentages and big arms (and perhaps a recent positive Covid-19 test and controversy for the latter). You might not think of cryptocurrency—but that’s all changing, thanks to this duo and several other notable NFL players who are opting… [Read More]